This Dividend Stock Just Hit a Major Milestone. Time to Buy?

• Medtronic earned regulatory clearance successful the U.S. for its Hugo robotic-assisted country system.

• This instrumentality volition instrumentality clip to person a worldly interaction connected the company's fiscal results.

• Still, Medtronic has a beardown business, aggregate maturation opportunities, and a fantastic dividend program.

• 10 stocks we similar amended than Medtronic ›

Medtronic (NYSE: MDT), a aesculapian instrumentality specialist, has performed good this year. That's contempt the menace of tariffs, which are having a worldly interaction connected its earnings. However, its fiscal results person been beardown contempt this headwind, and its outlook for the adjacent twelvemonth remains bright.

Things got adjacent amended precocious erstwhile Medtronic received U.S. regulatory clearance for a instrumentality that could go an important maturation operator for the healthcare giant. Let's look much into it, and determine whether these developments marque Medtronic an charismatic banal to put in.

Medtronic began processing the Hugo system, a robotic-assisted country (RAS) device, implicit 10 years ago. The institution identified a tremendous underpenetrated accidental successful the RAS market, due to the fact that the adoption of these machines has been insufficient to conscionable the measurement of procedures eligible for robotic assistance.

As absorption observed successful 2023, less than 5% of surgeries that tin beryllium done robotically are being done so, adjacent though RAS confers benefits. Robot devices assistance execute minimally invasive surgeries. They usage tiny instruments inserted wrong patients' bodies done tiny incisions. They don't necessitate ample incisions to summation nonstop entree to organs, arsenic with unfastened surgeries.

The Hugo strategy was successful usage for years successful assorted countries, but it had yet to person clearance successful the United States -- the astir lucrative market. That's changed now. Medtronic precocious announced that the Hugo strategy has been approved for usage successful urologic procedures successful the U.S. What does this mean for Medtronic's fiscal results?

The Hugo strategy volition person to look disconnected against Intuitive Surgical's da Vinci strategy successful this indication. It's worthy pointing retired that urology was the da Vinci system's third-largest specialty successful the U.S. arsenic of past year, and the largest extracurricular the U.S. So, this marketplace represents a non-negligible percent of Intuitive Surgical's gross from the da Vinci system, by acold its astir important maturation driver. What does that mean for Medtronic?

The institution volition person to person healthcare facilities to opt for the Hugo implicit the much established (and much thoroughly studied successful real-world procedures) da Vinci system. It volition besides instrumentality clip for Medtronic's caller instrumentality to ramp up process volume.